Skip to main content
. 2021 Sep 28;12(5):e02220-21. doi: 10.1128/mBio.02220-21

FIG 2.

FIG 2

Inhibition of SARS-CoV-2 replication in Vero cells by leupeptin. (A) Inhibitory curve of leupeptin against SARS-CoV-2 replication. (B) Relative concentration of vRNA present in the supernatant at 72 h postinfection determined by reverse transcription-quantitative PCR (qRT-PCR) analysis after leupeptin treatment. Continued t test P values indicate statistical significance (**, P < 0.01; ***, P < 0.001).